Cardiovascular risk assessment and lipid modification

This quality standard covers identifying and assessing cardiovascular risk in adults without cardiovascular disease, and treatment to prevent primary and secondary cardiovascular disease. It describes high-quality care in priority areas for improvement.

Last reviewed: 23 July 2025

This quality standard updates and replaces the existing quality standard on cardiovascular risk assessment and lipid modification (published September 2015). The topic was identified for update following a review of quality standards. The review identified updated guidance on cardiovascular disease: risk assessment and reduction, including lipid modification.

For more information, see update information.

How to use NICE quality standards and how we develop them

Quality standards help you improve the quality of care you provide or commission. They apply in England and Wales (see the UK government website and Welsh government website). Decisions on how they apply in Scotland and Northern Ireland are made by ministers in the Scottish government and Northern Ireland Executive.

Find out how to use quality standards and how we develop them.